Ginsenoside Re

Synonym: 52286-59-6; (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

MDL: MFCD00133369
CAS Number: 52286-59-6
PubChem Substance ID: 468591930
PubChem CID: 441921

Product Size

25 mg; 100 mg; 250 mg

Price

Datasheet

MSDS

Properties

Molecular Weight

947.17

Molecular Formula

C₄₈H₈₂O₁₈

Form

White powder

Purity

>98.0%, determined by HPLC.

Applications

Ginsenoside Re can be used for content analysis, substance identification and chemical synthesis.

Safety Information

Personal Protective Equipment

Gloves, eyeshields, N95 mask